88441516 - KYMAB

Information

• Trademark
• 88441516

• Source

• Serial Number

  88441516

• Registration Number

  6473731

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  May 22, 2019
  5 years ago

• Registration Date

  September 07, 2021
  3 years ago

• Transaction Date

  September 07, 2021
  3 years ago

• Status Date

  September 07, 2021
  3 years ago

• Published for Opposition Date

  March 23, 2021
  3 years ago

• Location Date

  September 07, 2021
  3 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  MANGUBAT, ALEXANDER GE

• Attorney Docket Number

  86291.020191

  Attorney Name

  Mark H. Tidman

  Law Office Assigned Location Code

  N30

• Owners

  • Kymab Limited

Case File Statements

• GS0051: Pharmaceutical and medical preparations containing monoclonal antibodies for the treatment and prophylaxis of medical conditions in humans, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology; Veterinary preparations containing monoclonal antibodies for treatment and prophylaxis of medical conditions in humans, namely, cancer, inflammatory, autoimmune and infectious diseases, and medical diagnostics; sanitary preparations containing monoclonal antibodies for medical purposes; dietetic food and beverages containing monoclonal antibodies, for medical and veterinary use; dietary supplements containing monoclonal antibodies for human beings and animals; dietary supplements containing monoclonal antibodies; Pharmaceutical preparations containing monoclonal antibodies for the treatment of treatment and prophylaxis of medical conditions in humans, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases and in the field of antibodies and immuno-oncology
• GS0421: Scientific, medical and technological services, namely, scientific research, analysis and testing in the field of medical conditions in humans, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology, and scientific research, analysis and testing in the field of antibodies and cell repertoires and research, development and design in the field of science, medicine, and technology; industrial analysis and industrial research services, namely, testing, analysis, and evaluation of the goods of others to assure compliance with industry standards; design and development of computer hardware and software; design and development of hardware and software for analysis and testing in the field of antibodies and biological cells and genetic discovery and clinical development; Clinical research in the field of medical conditions in humans, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies, immuno-oncology, inflammation, haematology and infectious disease; Conducting clinical trials for others in the field of antibodies, and medical conditions, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology; conducting clinical trials for pharmaceutical products for others in the field of medical conditions, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology; scientific and medical screening and assaying of medical conditions, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology; scientific and medical screening and assaying in the field of genetic discovery, clinical development, antibodies and biological cells; chemical analysis; chemical research
• GS0441: Medical services; diagnostic and prognostic medical services; veterinary services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; pharmaceutical consultation in the nature of pharmacy advice; medical and health services in the nature of the treatment and prophylaxis of medical conditions in humans, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics; Medical screening

Case File Event Statements

• 9/7/2021 - 3 years ago

  37 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 8/1/2021 - 3 years ago

  36 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Type: ETOP

• 4/21/2021 - 3 years ago

  35 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF

• 3/23/2021 - 3 years ago

  34 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 3/23/2021 - 3 years ago

  33 - PUBLISHED FOR OPPOSITION Type: PUBO

• 3/3/2021 - 3 years ago

  32 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 2/17/2021 - 3 years ago

  31 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 2/17/2021 - 3 years ago

  30 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 2/17/2021 - 3 years ago

  29 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 2/17/2021 - 3 years ago

  28 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 2/17/2021 - 3 years ago

  27 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 10/9/2020 - 4 years ago

  26 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 10/9/2020 - 4 years ago

  25 - NON-FINAL ACTION E-MAILED Type: GNRT

• 10/9/2020 - 4 years ago

  24 - NON-FINAL ACTION WRITTEN Type: CNRT

• 8/22/2020 - 4 years ago

  23 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/21/2020 - 4 years ago

  22 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/21/2020 - 4 years ago

  21 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 3/16/2020 - 4 years ago

  20 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 3/16/2020 - 4 years ago

  19 - NON-FINAL ACTION E-MAILED Type: GNRT

• 3/16/2020 - 4 years ago

  18 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/9/2020 - 4 years ago

  17 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 2/21/2020 - 4 years ago

  16 - ELECTRONIC RECORD REVIEW COMPLETE Type: FIXD

• 2/21/2020 - 4 years ago

  15 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Type: ERRR

• 2/14/2020 - 4 years ago

  14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 2/14/2020 - 4 years ago

  13 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 2/14/2020 - 4 years ago

  12 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 2/14/2020 - 4 years ago

  11 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 2/14/2020 - 4 years ago

  10 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 1/29/2020 - 4 years ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 1/28/2020 - 4 years ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 1/28/2020 - 4 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 8/9/2019 - 5 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 8/9/2019 - 5 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 8/9/2019 - 5 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 8/9/2019 - 5 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 6/6/2019 - 5 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 5/25/2019 - 5 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP